Tashir MEDIKA

Arsen Galstyan serves as the firm's Managing Partner and CEO, leading day-to-day investment strategy and healthcare operations. He reports to Samvel Karapetyan, the founder and ultimate beneficial owner, who established the vehicle as a distinct vertical within the broader Tashir Group conglomerate. Decision-making authority on large capital commitments — such as the Hospital of the Future at Skolkovo — appears to rest with Karapetyan directly.

Tashir MEDIKA sources deals primarily through Tashir Group's regional business networks and municipal relationships across Russia. The firm's real estate development background provides direct access to land parcels, construction permits, and operational licenses that make greenfield hospital development possible. For HealthTech co-investments, the firm has partnered with venture platforms like Unicorn Capital Partners to access early-stage diagnostic AI and digital health startups.

Tashir MEDIKA operates as a dedicated healthcare investment arm of Tashir Group and functions like a corporate investment division rather than a traditional family office or third-party asset manager. It does not raise outside capital and deploys exclusively from the parent group's balance sheet. Its model resembles a holding company that both acquires and operates medical assets directly.

The firm targets buyout, late-stage expansion, and restructuring opportunities in Russia's healthcare services sector. Its most visible commitments are controlling stakes in operating hospitals and clinics, with occasional minority co-investments in expansion-stage HealthTech companies developing clinical software and diagnostic tools.

Tashir MEDIKA does not appear to invest in early-stage biotech, pharmaceutical R&D, or non-Russian healthcare infrastructure. The firm's mandate excludes passive fund commitments to third-party GPs, and it has no observable interest in Western healthcare assets, keeping the portfolio tightly aligned with the Tashir Group's domestic and CIS-focused orientation.

The Tashir Foundation operates as a separate philanthropic entity under Samvel Karapetyan's control, funding medical and social welfare programs that are legally distinct from Tashir MEDIKA's commercial investments. However, the two share an overlapping geographic focus in Russia and Armenia, and the Republican Medical Center in Stepanakert, Artsakh, sits as a foundation-linked facility that mirrors Tashir MEDIKA's broader healthcare infrastructure thesis.

Tashir MEDIKA operates exclusively through direct deals — acquiring and developing hospital assets and making selective co-investments in private companies. There is no public record of the firm committing capital to blind-pool private equity, venture, or credit funds managed by external GPs. Its sole external investment partnerships to date are co-investments alongside fellow strategic investors like Unicorn Capital Partners.